Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects".

Saved in:
Bibliographic Details
Title: Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects".
Authors: Uebelhack R; Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany., Bongartz U; Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany., Seibt S; Analyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, Germany., Bothe G; Analyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, Germany., Chong PW; Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia., De Costa P; InQpharm Group Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia., Wszelaki N; Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia.
Source: Journal of obesity [J Obes] 2019 Jul 11; Vol. 2019, pp. 6189724. Date of Electronic Publication: 2019 Jul 11 (Print Publication: 2019).
Publication Type: Published Erratum
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101526295 Publication Model: eCollection Cited Medium: Internet ISSN: 2090-0716 (Electronic) Linking ISSN: 20900708 NLM ISO Abbreviation: J Obes Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2090-0716
DOI:10.1155/2019/6189724